There is a significant disagreement between the experimental and theoretical plasma Stark shift of the hydrogenlike helium Paschen-α line (λ=468.568nm). Here, it is demonstrated that the controversy can be resolved by accounting for the plasma polarization shift and other related effects arising from the charged plasma particles penetrating the wave-function extent of the bound electron. For experimental verification, a laser-induced helium plasma with n_{e}=1.50×10^{24}m^{-3} and T_{e}=68200K, as independently determined by using the Thomson scattering method, was studied. Excellent agreement is observed between the theoretical and experimental line width and line shift, and more generally, for the entire line shape.

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.106.L023202DOI Listing

Publication Analysis

Top Keywords

plasma stark
8
plasma
5
stark paschen-α
4
paschen-α resolution
4
resolution disagreement
4
disagreement experiment
4
experiment theory
4
theory disagreement
4
disagreement experimental
4
experimental theoretical
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Background: The MarkVCID consortium was established to address the paucity of biomarkers for vascular contributions to cognitive impairment and dementia (VCID), a leading cause of dementia. Plasma neurofilament light (NfL), a neuroaxonal injury marker elevated in several neurological and neurodegenerative diseases, was selected as one of the first biomarkers to be examined. We performed comprehensive instrumental and clinical validation of the Quanterix Simoa NfL assay using the first MarkVCID cohort.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

University of Kentucky College of Medicine, Sanders-Brown Center on Aging, Lexington, KY, USA.

Background: We currently lack in the dementia field accurate, noninvasive, quick, and affordable screening tools for brain dysfunctions associated with early subtle risk of mild cognitive impairment (MCI). Our Kentucky aging cohort demonstrates that asymptomatic older individuals with MCI-like frontal memory-related brainwave patterns convert to MCI within a short 5-year period, as opposed to individuals with NC-like patterns (1) that remain normal 10 years later (2). Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease (3).

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) blood biomarkers alone can detect amyloid-β (Aβ) pathology in cognitively unimpaired (CU) individuals. We assessed whether combining different plasma biomarkers improves the detection of Aβ-positivity and identifies rapid amyloid deposition in CU individuals.

Method: CU participants from the ALFA+ cohort were included.

View Article and Find Full Text PDF

Background: Non-invasive biofluid and MRI measures of blood-brain-barrier (BBB) dysfunction may aid early detection of cerebral small vessel disease (cSVD). Plasma markers of astrocytic function and injury, such as S100 calcium-binding protein B (S100b), have gained increased attention in relation to BBB integrity and cognition. Here we explored the inter-relationships between plasma S100b levels, an MRI measure of water exchange rate across the BBB (kw), and cognitive performance among older adults.

View Article and Find Full Text PDF

Background: Fluid biomarkers provide a convenient way to predict AD pathophysiology. However, few studies have focused on determining associations with tau neurofibrillary tangle pathology in the early preclinical AD continuum, relevant to prevention strategies.

Methods: Ninety-nine cognitively unimpaired individuals from the ALFA+ cohort with valid F-RO-948 and F-flutemetamol PET, T1-weighted MRI, cognition, CSF, and plasma biomarkers were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!